BACKGROUND: Structural abnormality of the substantia nigra can be detected by transcranial sonography in neuropsychiatric disorders such as Parkinson disease and restless legs syndrome. We investigated echogenicity of the substantia nigra as a potential structural marker for dysfunction of the nigrostriatal dopamine system in children with attention-deficit hyperactivity disorder (ADHD). METHODS: We used a blinded design and determined echogenicity of the substantia nigra by use of transcranial sonography in 22 children with ADHD and 22 healthy controls matched for age and sex. RESULTS: The echogenic substantia nigra area was significantly larger in ADHD patients than in healthy controls (F(1,42) = 9.298, p = 0.004, effect size = 0.92). We found no effects of age or sex. LIMITATIONS: Owing to a lack of dimensional assessment, we could not analyze the correlation between echogenicity and clinical symptoms. CONCLUSION: Our results support the hypothesis that the nigrostriatal dopaminergic system is abnormal in children with ADHD.
BACKGROUND:Structural abnormality of the substantia nigra can be detected by transcranial sonography in neuropsychiatric disorders such as Parkinson disease and restless legs syndrome. We investigated echogenicity of the substantia nigra as a potential structural marker for dysfunction of the nigrostriatal dopamine system in children with attention-deficit hyperactivity disorder (ADHD). METHODS: We used a blinded design and determined echogenicity of the substantia nigra by use of transcranial sonography in 22 children with ADHD and 22 healthy controls matched for age and sex. RESULTS: The echogenic substantia nigra area was significantly larger in ADHDpatients than in healthy controls (F(1,42) = 9.298, p = 0.004, effect size = 0.92). We found no effects of age or sex. LIMITATIONS: Owing to a lack of dimensional assessment, we could not analyze the correlation between echogenicity and clinical symptoms. CONCLUSION: Our results support the hypothesis that the nigrostriatal dopaminergic system is abnormal in children with ADHD.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Guilherme Polanczyk; Maurício Silva de Lima; Bernardo Lessa Horta; Joseph Biederman; Luis Augusto Rohde Journal: Am J Psychiatry Date: 2007-06 Impact factor: 18.112
Authors: Elizabeth Hotham; Miranda Haberfield; Susan Hillier; Jason M White; Gabrielle Todd Journal: J Neural Transm (Vienna) Date: 2017-12-12 Impact factor: 3.575
Authors: Karen Curtin; Annette E Fleckenstein; Brooks R Keeshin; Deborah A Yurgelun-Todd; Perry F Renshaw; Ken R Smith; Glen R Hanson Journal: Neuropsychopharmacology Date: 2018-09-12 Impact factor: 7.853
Authors: Melinda Barkhuizen; Fleur J P van Dijck; Reint K Jellema; Ruth Gussenhoven; Imke Engelbertink; Ralph van Mechelen; Jack P M Cleutjens; Matthias Seehase; Harry W M Steinbusch; Luc J Zimmermann; A W Danilo Gavilanes; Boris W Kramer Journal: Pediatr Res Date: 2018-05-09 Impact factor: 3.756